Cyclin‐dependent kinase inhibitors for treating cancer
Year: 2001
Type: review
Source: Medicinal Research Reviews
DOI: 10.1002/med.1021
Author: Peter L. Toogood
Institution: Pfizer (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1978985435
